Northeast Bank (NASDAQ:NBN) reported quarterly earnings of $1.12 per share. This is a 6.67 percent decrease over earnings of $1.20 per share from the same period last year.
Morgan Stanley Maintains Overweight on Arcutis Biotherapeutics, Lowers Price Target to $50
Morgan Stanley analyst Vikram Purohit maintains Arcutis Biotherapeutics (NASDAQ:ARQT) with a Overweight and lowers the price target from $51 to $50.